Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors Meeting Abstract


Authors: Cohen, J. V.; Garyantes, T. K.; Muller, C.; Natale, C. A.; Orloff, M.; Patel, S.; Rodon, J.; Shoushtari, A. N.
Abstract Title: Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sep 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S746
Language: English
ACCESSION: WOS:001326612901440
DOI: 10.1016/j.annonc.2024.08.2140
PROVIDER: wos
Notes: Meeting Abstract: 1137P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors